⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

AMGN

Amgen Inc.

Healthcare · Drug Manufacturers - General

391.27USD

-1.9000 (-0.48%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 391.27
P/E24.2
Dvd Ind Yld2.6%
P/B18.10
P/S5.6
Curr EV/T12M EBITDA18.0
Mkt Cap (USD)211.5B
Curr EV (USD)254.8B
2)

Per Share Data

EPS T12M16.10
DPS9.72
Bk Val Per Sh21.62
Rev/Sh70.03
Cash/Sh25.88
Curr Shares Out540.6M
FCF/Sh18.70
3)

Cash Flow Analysis

P/CF17.0
Curr P/FCF20.8
CF/NI1.4
Dvd P/O60.4%
Cash Gen/Cash Reqd1.6
Csh Dvd Cov2.4
CFO/Sales32.8%
Eff Interest Rate4.7%
4)

Growth Potential

Dil EPS 1Y Gr88.2%
Cap 1Y Gr-4.1%
BPS 1Y Gr47.0%
R&D To Sales—
Retention Rate39.6%
Rev 1Y Gr10.0%
FCF 1Y Gr-22.1%
Assets 1Y Gr-1.4%
5)

Profitability

EBITDA14.1B
EBIT11.4B
Operating Margin30.0%
Pretax Margin27.0%
Net Margin23.0%
ROA9.5%
ROE91.5%
ROC14.1%
Asset Turnover0.42
6)

Structure

Current Ratio1.37
Quick Ratio0.95
Debt/Assets59.9%
Debt/Com Eq490.3%
Net Debt/EBITDA3.07
Tot Debt/Capital83.1%
Gross Margin69.5%
EBIT/Int Exp4.3

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.